Publications by authors named "Nathalie Scholler"

54Publications

Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms.

Sci Rep 2019 03 25;9(1):5101. Epub 2019 Mar 25.

University of Arkansas for Medical Sciences, Department of Biochemistry and Molecular Biology, Little Rock, AR, 72205, USA.

View Article and Find Full Text PDF
March 2019

Selection of Antibody Fragments by Yeast Display.

Methods Mol Biol 2018 ;1827:211-233

Kite, a Gilead Company, Santa Monica, CA, USA.

View Article and Find Full Text PDF
April 2019

Molecular Imaging of Mesothelin-Expressing Ovarian Cancer with a Human and Mouse Cross-Reactive Nanobody.

Mol Pharm 2018 04 28;15(4):1403-1411. Epub 2018 Feb 28.

Biosciences Division , SRI International , 333 Ravenswood Avenue , Menlo Park , California 94025 , United States.

View Article and Find Full Text PDF
April 2018

Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.

Mol Ther 2016 Nov 21;24(11):1987-1999. Epub 2016 Jul 21.

Department of Pathology and Laboratory Medicine, Center for Cellular Immunotherapies, Philadelphia, Pennsylvania, USA; Department of Obstetrics and Gynecology, Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address:

View Article and Find Full Text PDF
November 2016

Isolation and Validation of Anti-B7-H4 scFvs from an Ovarian Cancer scFv Yeast-Display Library.

Methods Mol Biol 2015 ;1319:37-49

Department of Oncology, Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.

View Article and Find Full Text PDF
March 2016

ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.

Blood 2014 Aug 1;124(7):1070-80. Epub 2014 Jul 1.

Abramson Cancer Center and the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;

View Article and Find Full Text PDF
August 2014

Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses.

Oncoimmunology 2013 Aug 31;2(8):e25913. Epub 2013 Jul 31.

Department of Oncology; Ludwig Cancer Research Center; University of Lausanne; Lausanne, Switzerland.

View Article and Find Full Text PDF
August 2013

Facile immunotargeting of nanoparticles against tumor antigens using site-specific biotinylated antibody fragments.

J Biomed Nanotechnol 2013 Oct;9(10):1686-97

Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

View Article and Find Full Text PDF
October 2013

Immunocompetent mouse model of ovarian cancer for in vivo imaging.

Methods Mol Biol 2013 ;1049:425-33

Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA, USA.

View Article and Find Full Text PDF
March 2014

Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.

Cancer Res 2013 Aug 30;73(15):4820-9. Epub 2013 May 30.

Department of Obstetrics and Gynecology, Ovarian Cancer Research Center, and Departments of Pathology and Laboratory Medicine and Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article and Find Full Text PDF
August 2013

Coating Evaluation and Purification of Monodisperse, Water-Soluble, Magnetic Nanoparticles Using Sucrose Density Gradient Ultracentrifugation.

Chem Mater 2012 Nov 19;24(21):4008-4010. Epub 2012 Oct 19.

Penn Ovarian Cancer Research Center and Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, University of Pennsylvania, Pennsylvania 19104, United States.

View Article and Find Full Text PDF
November 2012

Selection of antibody fragments by yeast display.

Methods Mol Biol 2012 ;907:259-80

Center for Research on Reproduction and Women's Health, Penn Ovarian Cancer Research Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA,

View Article and Find Full Text PDF
December 2012

Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.

BMC Biotechnol 2012 May 7;12:23. Epub 2012 May 7.

Medicine and Research Services, Philadelphia VA Medical Center, PA 19104, USA.

View Article and Find Full Text PDF
May 2012

A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor.

Cancer Res 2012 Apr 7;72(7):1844-52. Epub 2012 Feb 7.

Department of Obstetrics and Gynecology, Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article and Find Full Text PDF
April 2012

Oncology biomarkers for gynecologic malignancies.

Front Biosci (Elite Ed) 2012 Jan 1;4:1097-110. Epub 2012 Jan 1.

Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.

View Article and Find Full Text PDF
January 2012

Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody.

PLoS One 2011 6;6(12):e28386. Epub 2011 Dec 6.

Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

View Article and Find Full Text PDF
July 2012

Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor.

Mol Ther 2012 Mar 29;20(3):633-43. Epub 2011 Nov 29.

Department of Obstetrics and Gynecology, Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article and Find Full Text PDF
March 2012

An orthotopic model of serous ovarian cancer in immunocompetent mice for in vivo tumor imaging and monitoring of tumor immune responses.

J Vis Exp 2010 Nov 28(45). Epub 2010 Nov 28.

Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology, University of Pennsylvania-School of Medicine, USA.

View Article and Find Full Text PDF
November 2010

Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.

J Immunol Methods 2011 Jan 15;363(2):221-32. Epub 2010 Sep 15.

Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Women's Health (CRRWH), Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article and Find Full Text PDF
January 2011

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

J Natl Cancer Inst 2010 Jan 30;102(1):26-38. Epub 2009 Dec 30.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, PO Box 19024, M3-A410, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF
January 2010

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Gynecol Oncol 2010 Mar 28;116(3):378-83. Epub 2009 Nov 28.

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF
March 2010

Antifouling surface layers for improved signal-to-noise of particle-based immunoassays.

Langmuir 2009 Dec;25(23):13510-5

Biomarker Research and Development Centre, Level 5 East, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD 4072, Australia.

View Article and Find Full Text PDF
December 2009

Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?

Biomark Med 2009 Jun;3(3):275-288

University of Pennsylvania School of Medicine, 421 Curie Boulevard, BRBII/III, PA, USA.

View Article and Find Full Text PDF
June 2009

Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.

IDrugs 2009 Apr;12(4):207-10

University of Pennsylvania, 1309 Biomedical Research Building II/III, 421 Curie Boulevard, Philadelphia, PA 19104-6160, USA.

View Article and Find Full Text PDF
April 2009

Maternal mortality from systemic illness: unraveling the contribution of the immune response.

Am J Obstet Gynecol 2009 Apr;200(4):430.e1-8

Maternal and Child Health Research Program, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article and Find Full Text PDF
April 2009

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery.

J Transl Med 2008 Jul 24;6:41. Epub 2008 Jul 24.

Center for Research on Early Detection and Cure of Ovarian Cancer, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article and Find Full Text PDF
July 2008

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

Cancer 2008 Aug;113(3):484-9

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF
August 2008

CA125 in ovarian cancer.

Biomark Med 2007 Dec;1(4):513-23

Center for Research on Early Detection & Cure of Ovarian Cancer School of Medicine, University of Pennsylvania Biomedical Research Building (BRB) II/III, Suite 1355 421 Curie Blvd, PA 19104-6080, USA.

View Article and Find Full Text PDF
December 2007

Use of high density antibody arrays to validate and discover cancer serum biomarkers.

Mol Oncol 2007 Dec 30;1(3):313-20. Epub 2007 Aug 30.

Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF
December 2007

Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.

Cancer Lett 2007 Oct 7;255(2):263-74. Epub 2007 Jun 7.

Molecular Diagnositics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article and Find Full Text PDF
October 2007

Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.

J Immunol Methods 2006 Dec 30;317(1-2):132-43. Epub 2006 Oct 30.

Translational Outcomes Research Group, Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article and Find Full Text PDF
December 2006

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.

Cancer Lett 2007 Mar 4;247(1):130-6. Epub 2006 May 4.

Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF
March 2007

Bead-based ELISA for validation of ovarian cancer early detection markers.

Clin Cancer Res 2006 Apr;12(7 Pt 1):2117-24

Translational Outcomes Research Laboratory, Fred Hutchinson Cancer Research Center, Public Health Sciences, and Harborview Medical Center, University of Washington, Seattle, Washington, USA.

View Article and Find Full Text PDF
April 2006

Cutting edge: CD83 regulates the development of cellular immunity.

J Immunol 2002 Mar;168(6):2599-602

Laboratories of. Tumor Immunology, and Immunobiology, Pacific Northwest Research Institute, Seattle, WA 98122, USA.

View Article and Find Full Text PDF
March 2002